Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Tandem Diabetes Care Inc (TNDM)

  • Business News
  • June 10, 2025, 12:31 UTC
  • 2

Tandem Diabetes Care Announces Agreement with Abbott for Integration of Automated Insulin Delivery Systems with Future Glucose-Ketone Sensor

Market reaction Comment Full text

Day One Biopharmaceuticals Inc (DAWN)

  • Business News
  • June 10, 2025, 12:31 UTC
  • 1

Day One Appoints Michael Vasconcelles, M.D., as Headof Research and Development

Market reaction Comment Full text

Insulet Corporation (PODD)

  • Business News
  • June 10, 2025, 12:30 UTC
  • 2

Insulet - Insulet’s Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users

Market reaction Comment Full text

Vivani Medical Inc. (VANI)

  • Business News
  • June 10, 2025, 12:30 UTC
  • 1

Vivani Medical to Present at the 2025 BIO International Convention

Market reaction Comment Full text

Oragenics Inc. (OGEN)

  • Business News
  • June 10, 2025, 12:30 UTC
  • 2

Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium

Market reaction Comment Full text

Gain Therapeutics Inc. (GANX)

  • Business News
  • June 10, 2025, 12:18 UTC
  • 1

Gain Therapeutics to Participate in Upcoming Investor Conferences

Market reaction Comment Full text

Outlook Therapeutics Inc. (OTLK)

  • Business News
  • June 10, 2025, 12:05 UTC
  • 1

Outlook Therapeutics® Announces SMC Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD

Market reaction Comment Full text

Novo Nordisk (NVO)

  • Business News
  • June 10, 2025, 12:04 UTC
  • 2

ADA 2025: Novo Nordisk highlights strong portfolio data with new semaglutide and CagriSema results, redefining possibilities in obesity and diabetes care

Market reaction Comment Full text

Vanda Pharmaceuticals Inc (VNDA)

  • Business News
  • June 10, 2025, 12:02 UTC
  • 1

Vanda Pharmaceuticals Announces First Patient Dosed in a Trial Evaluating VCA-894A in Charcot-Marie-Tooth disease Type 2S

Market reaction Comment Full text

X4 Pharmaceuticals Inc. (XFOR)

  • Business News
  • June 10, 2025, 12:02 UTC
  • 1

X4 Pharmaceuticals Granted Fast Track Designation for Mavorixafor for the Treatment of Chronic Neutropenia by U.S. FDA

Market reaction Comment Full text
  • Previous
  • 108
  • 109
  • 110
  • 111
  • 112
  • Next

Search

News categories

  • Technical Exchange News(9382)
  • Event(407)
  • SEC News(153280)
  • FDA Approval(8758)
  • Company Report(721)
  • Business News(104605)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin